SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes

References

• Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):v1–96.
   PubMedGoogle Scholar
• Lara-Velazquez M, Al-Kharboosh R, Jeanneret S, et al. Advances in brain tumor surgery for glioblastoma in adults. Brain Sci. 2017;7(12):166.
   PubMed Web of Science ®Google Scholar
• Chiblak S, Tang Z, Lemke D, et al. Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche. JCI Insight. 2019;4(2):e123837.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Rinne ML, Wykosky J, et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012;26(8):756–784.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741.
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125(1):42–46.
   PubMed Web of Science ®Google Scholar
• Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016;30(17):1913–1930.
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, et al. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol. 2011;8(9):528–539.
   PubMed Web of Science ®Google Scholar
• Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest. 2015;125(1):1–4.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726–734.
   PubMed Web of Science ®Google Scholar
• Rosenfeld MR, Ye X, Supko JG, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 2014;10(8):1359–1368.
   PubMed Web of Science ®Google Scholar
• Spinler K, Bajaj J, Ito T, et al. A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. Nat Commun. 2020;11(1):5998.
   PubMed Web of Science ®Google Scholar
• Jary M, Hasanova R, Vienot A, et al. Molecular description of ANGPT2 associated colorectal carcinoma. Int J Cancer. 2020;147(7):2007–2018.
   PubMed Web of Science ®Google Scholar
• Malkomes P, Lunger I, Oppermann E, et al. Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53. Oncogene. 2021;40(25):4352–4367.
   PubMed Web of Science ®Google Scholar
• Sahani MH, Itakura E, Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy. 2014;10(3):431–441.
   PubMed Web of Science ®Google Scholar
• Yao W, Rose JL, Wang W, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;568(7752):410–414.
   PubMed Web of Science ®Google Scholar
• Burbach BJ, Friedl A, Mundhenke C, et al. Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol. 2003;22(2):163–177.
   PubMed Web of Science ®Google Scholar
• Birgisdottir AB, Lamark T, Johansen T. The LIR motif - crucial for selective autophagy. J Cell Sci. 2013;126(Pt 15):3237–3247.
   PubMed Web of Science ®Google Scholar
• Wang Z, Miao G, Xue X, et al. The Vici Syndrome Protein EPG5 Is a Rab7 Effector that Determines the Fusion Specificity of Autophagosomes with Late Endosomes/Lysosomes. Mol Cell. 2016;63(5):781–795.
   PubMed Web of Science ®Google Scholar
• Cicchetti F, David LS, Siddu A, et al. Cysteamine as a novel disease-modifying compound for Parkinson’s disease: over a decade of research supporting a clinical trial. Neurobiol Dis. 2019;130:104530.
   PubMed Web of Science ®Google Scholar
• Jenkins LM, Horst B, Lancaster CL, et al. Dually modified transmembrane proteoglycans in development and disease. Cytokine Growth Factor Rev. 2018;39:124–136.
   PubMed Web of Science ®Google Scholar
• Sayyad MR, Puchalapalli M, Vergara NG, et al. Syndecan-1 facilitates breast cancer metastasis to the brain. Breast Cancer Res Treat. 2019;178(1):35–49.
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Fernandes A, Aguilar-Pimentel JA, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev. 2018;47:214–277.
   PubMed Web of Science ®Google Scholar
• Leicht DT, Kausar T, Wang Z, et al. TGM2: a cell surface marker in esophageal adenocarcinomas. J Thorac Oncol. 2014;9(6):872–881.
   PubMed Web of Science ®Google Scholar
• Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and −4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272(23):14713–14720.
   PubMed Web of Science ®Google Scholar
• Chen K, Williams KJ. Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor. J Biol Chem. 2013;288(20):13988–13999.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee MS. Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10(6):322–337.
   PubMed Web of Science ®Google Scholar
• You Z, Xu Y, Wan W, et al. TP53INP2 contributes to autophagosome formation by promoting LC3-ATG7 interaction. Autophagy. 2019;15(8):1309–1321.
   PubMed Web of Science ®Google Scholar
• Morita K, Hama Y, Izume T, et al. Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation. J Cell Biol. 2018;217(11):3817–3828.
   PubMed Web of Science ®Google Scholar
• Osawa T, Kotani T, Kawaoka T, et al. Atg2 mediates direct lipid transfer between membranes for autophagosome formation. Nat Struct Mol Biol. 2019;26(4):281–288.
   PubMed Web of Science ®Google Scholar
• Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021;22(11):733–750.
   PubMed Web of Science ®Google Scholar
• McEwan DG, Popovic D, Gubas A, et al. PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. Mol Cell. 2015;57(1):39–54.
   PubMed Web of Science ®Google Scholar
• Jiang P, Nishimura T, Sakamaki Y, et al. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol Biol Cell. 2014;25(8):1327–1337.
   PubMed Web of Science ®Google Scholar
• Pu J, Guardia CM, Keren-Kaplan T, et al. Mechanisms and functions of lysosome positioning. J Cell Sci. 2016;129(23):4329–4339.
   PubMed Web of Science ®Google Scholar
• Gundemir S, Colak G, Tucholski J, et al. Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta. 2012;1823(2):406–419.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Bravo-San PJ, et al. Autophagy in malignant transformation and cancer progression. Embo J. 2015;34(7):856–880.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang Y, Liu J, et al. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy. 2021;17(4):948–960.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shoji-Kawata S, Sumpter RJ, et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A. 2013;110(51):20364–20371.
   PubMed Web of Science ®Google Scholar
• Ishaq M, Ojha R, Sharma AP, et al. Autophagy in cancer: recent advances and future directions. Semin Cancer Biol. 2020;66:171–181.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9(9):1167–1181.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zheng W, Zhu L, et al. LACTB2 renders radioresistance by activating PINK1/Parkin-dependent mitophagy in nasopharyngeal carcinoma. Cancer Lett. 2021;518:127–139.
   PubMed Web of Science ®Google Scholar
• Udristioiu A, Nica-Badea D. Autophagy dysfunctions associated with cancer cells and their therapeutic implications. Biomed Pharmacother. 2019;115:108892.
   PubMed Web of Science ®Google Scholar
• Liu H, He Z, Simon HU. Targeting autophagy as a potential therapeutic approach for melanoma therapy. Semin Cancer Biol. 2013;23(5):352–360.
   PubMed Web of Science ®Google Scholar
• Golden EB, Cho HY, Jahanian A, et al. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus. 2014;37(6):E12.
   PubMed Web of Science ®Google Scholar
• Hori YS, Hosoda R, Akiyama Y, et al. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells. J Neurooncol. 2015;122(1):11–20.
   PubMed Web of Science ®Google Scholar
• Compter I, Eekers D, Hoeben A, et al. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy. 2020;17(9):2604–2612.
   PubMed Web of Science ®Google Scholar
• Jorge A, Ung C, Young LH, et al. Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018;14(12):693–703.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Lippincott-Schwartz J, Yin XM, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011;17(4):654–666.
   PubMed Web of Science ®Google Scholar
• Prundean A, Youssov K, Humbert S, et al. A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington’s disease. Mov Disord. 2015;30(2):288–289.
   PubMed Web of Science ®Google Scholar
• Verny C, Bachoud-Levi AC, Durr A, et al. A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington’s disease. Mov Disord. 2017;32(6):932–936.
   PubMed Web of Science ®Google Scholar
• Jin JY, Mereniuk T, Yalamanchali A, et al. A framework for modeling radiation induced lymphopenia in radiotherapy. Radiother Oncol. 2020;144:105–113.
   PubMed Web of Science ®Google Scholar
• Abravan A, Faivre-Finn C, Kennedy J, et al. Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer. J Thorac Oncol. 2020;15(10):1624–1635.
   PubMed Web of Science ®Google Scholar
• Bacq ZM, Dechamps G, Fischer P, et al. Protection against x-rays and therapy of radiation sickness with beta-mercaptoethylamine. Science. 1953;117(3049):633–636.
   PubMed Web of Science ®Google Scholar
• Commisso C, Flinn RJ, Bar-Sagi D. Determining the macropinocytic index of cells through a quantitative image-based assay. Nat Protoc. 2014;9(1):182–192.
   PubMed Web of Science ®Google Scholar
• Zheng W, Chen Q, Liu H, et al. CD81 enhances radioresistance of glioblastoma by promoting nuclear translocation of rad51. Cancers (Basel). 2021;13(9):1998.
   PubMed Web of Science ®Google Scholar
• Brockmann MA, Ulmer S, Leppert J, et al. Analysis of mouse brain using a clinical 1.5 T scanner and a standard small loop surface coil. Brain Res. 2006;1068(1):138–142.
   PubMed Web of Science ®Google Scholar